Acyclovir Dosing for Oral Herpes Simplex (Cold Sores)
For oral herpes simplex (cold sores), the CDC recommends three equally effective oral acyclovir regimens: 800 mg twice daily for 5 days (most convenient), 400 mg three times daily for 5 days, or 200 mg five times daily for 5 days. 1
Recommended Dosing Options
All three regimens below are equally effective for treating recurrent oral herpes outbreaks 1:
- Acyclovir 800 mg orally twice daily for 5 days - This is the most convenient option with best adherence while maintaining equivalent efficacy 1
- Acyclovir 400 mg orally three times daily for 5 days - Standard middle-ground option 1, 2
- Acyclovir 200 mg orally five times daily for 5 days - Requires most frequent dosing but equally effective 1, 2
The 800 mg twice-daily regimen demonstrates superior clinical outcomes including shorter symptom duration (8.1 days vs 12.5 days with placebo), reduced pain duration (2.5 days vs 3.9 days), and fewer lesions developing (7% vs 26%) 1
Critical Timing for Treatment Initiation
Treatment must be initiated during the prodrome or within 2 days of lesion onset for maximum benefit. 1, 2
- Starting therapy after this 2-day window significantly reduces effectiveness 1, 2
- Most immunocompetent patients with recurrent disease experience limited benefit from delayed therapy 1, 2
Important Clinical Caveats
Oral acyclovir is strongly preferred over topical formulations - topical acyclovir cream is substantially less effective and its use is discouraged by the CDC 2
- Acyclovir neither eradicates latent virus nor affects subsequent risk, frequency, or severity of recurrences after discontinuation 1, 2
- Patients should abstain from activities that might spread the virus while lesions are present, though transmission can occur during asymptomatic periods 1, 2
Alternative Shorter Regimens
For patients prioritizing convenience, alternative agents offer shorter treatment courses 1:
- Valacyclovir 2 g twice daily for 1 day - comparable efficacy with superior convenience 1
- Famciclovir 1500 mg single dose - significantly reduces healing time (4.4 days vs 6.2 days with placebo) 1
Special Populations
For immunocompromised patients, more aggressive therapy is required 2, 3: